Deep and sustained response after venetoclax therapy in a patient with very advanced refractory myeloma with translocation t(11;14)

• Cyrille Touzeau,
• Steven Le Gouill,
• Béatrice Mahé,
• Jean Samuel Boudreault,
• Thomas Gastinne,
• Nicolas Blin,
• Hélène Caillon,
• Christelle Dousset,
• Martine Amiot,
• Philippe Moreau

Affiliations

Cyrille Touzeau

Department of Hematology, University Hospital, Nantes, France;CRCNA, INSERM, CNRS, University of Nantes, Nantes, France

Steven Le Gouill

Department of Hematology, University Hospital, Nantes, France;CRCNA, INSERM, CNRS, University of Nantes, Nantes, France

Béatrice Mahé

Department of Hematology, University Hospital, Nantes, France

Jean Samuel Boudreault

Department of Hematology, University Hospital, Nantes, France

Thomas Gastinne

Department of Hematology, University Hospital, Nantes, France

Nicolas Blin

Department of Hematology, University Hospital, Nantes, France

Hélène Caillon

Biochemistry Laboratory, University Hospital, Nantes, France

Christelle Dousset

Department of Hematology, University Hospital, Nantes, France;CRCNA, INSERM, CNRS, University of Nantes, Nantes, France

Martine Amiot

Department of Hematology, University Hospital, Nantes, France;CRCNA, INSERM, CNRS, University of Nantes, Nantes, France

Philippe Moreau

Department of Hematology, University Hospital, Nantes, France;CRCNA, INSERM, CNRS, University of Nantes, Nantes, France